Literature DB >> 574143

Exposure of platelet fibrinogen receptors by ADP and epinephrine.

J S Bennett, G Vilaire.   

Abstract

The role of fibrinogen as a cofactor for platelet aggregation was examined by measuring the binding of 125I-labeled human fibrinogen to gel-filtered human platelets both before and after platelet stimulation by ADP and epinephrine. Platelet stimulation by ADP resulted in the rapid, reversible binding of fibrinogen to receptors on the platelet surface. Fibrinogen binding increased as the concentration of ADP was increased from 0.1 to 2 microM, reaching a plateau at higher ADP concentrations. Binding occurred only after platelet stimulation and in the presence of divalent cations. However, fibrinogen binding did not occur to ADP-stimulated platelets from three patients with Glanzmann's thrombasthenia. Analysis of fibrinogen binding as a function of increasing fibrinogen concentration demonstrated that maximal platelet stimulation exposed approximately or equal to 45,000 binding sites per platelet with a dissociation constant of 80--170 nM. These fibrinogen binding parameters were essentially the same whether ADP or epinephrine was the platelet-stimulating agent. Thus, these studies demonstrate that platelet stimulation by ADP and epinephrine exposes a limited number of fibrinogen receptors on the platelet surface. Furthermore, these data suggest that the fibrinogen molecules bound to the platelet as a consequence of platelet stimulation are directly involved in the platelet aggregation response.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 574143      PMCID: PMC371288          DOI: 10.1172/JCI109597

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Peptide hormone receptors.

Authors:  K J Catt; M L Dufau
Journal:  Annu Rev Physiol       Date:  1977       Impact factor: 19.318

2.  The binding of calcium to bovine fibrinogen.

Authors:  G Marguerie; G Chagniel; M Suscillon
Journal:  Biochim Biophys Acta       Date:  1977-01-25

3.  HIGH SPECIFIC ACTIVITY LABELING OF INSULIN WITH 131-I.

Authors:  J L IZZO; W F BALE; M J IZZO; A RONCONE
Journal:  J Biol Chem       Date:  1964-11       Impact factor: 5.157

4.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

5.  Fibrinase. I. Purification of substrate and enzyme.

Authors:  A G LOEWY; K DUNATHAN; R KRIEL; H L WOLFINGER
Journal:  J Biol Chem       Date:  1961-10       Impact factor: 5.157

6.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

7.  Interaction of human fibrinogen with staphylococci: presence of a binding region on normal and abnormal fibrinogen variants and fibrinogen derivatives.

Authors:  J Hawiger; D K Hammond; S Timmons; A Z Budzynski
Journal:  Blood       Date:  1978-05       Impact factor: 22.113

8.  The binding of calcium to fibrinogen: some structural features.

Authors:  G Marguerie
Journal:  Biochim Biophys Acta       Date:  1977-09-27

Review 9.  Structure and function of fibrinogen.

Authors:  R F Doolittle
Journal:  Horiz Biochem Biophys       Date:  1977

10.  Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins.

Authors:  D R Phillips; P P Agin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

View more
  142 in total

1.  The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions.

Authors:  K V Vijayan; P J Goldschmidt-Clermont; C Roos; P F Bray
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Signal transduction by the platelet integrin alpha IIb beta 3: induction of calcium oscillations required for protein-tyrosine phosphorylation and ligand-induced spreading of stably transfected cells.

Authors:  A J Pelletier; S C Bodary; A D Levinson
Journal:  Mol Biol Cell       Date:  1992-09       Impact factor: 4.138

3.  Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets.

Authors:  M E Hensler; M Frojmovic; R G Taylor; R R Hantgan; J C Lewis
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

Review 4.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

5.  Affinity modulation of the alpha IIb beta 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor.

Authors:  T E O'Toole; J C Loftus; X P Du; A A Glass; Z M Ruggeri; S J Shattil; E F Plow; M H Ginsberg
Journal:  Cell Regul       Date:  1990-11

6.  Platelet aggregation is inhibited by phycolectins.

Authors:  K Matsubara; H Sumi; K Hori
Journal:  Experientia       Date:  1996-06-15

7.  Desialylation of Platelets by Pneumococcal Neuraminidase A Induces ADP-Dependent Platelet Hyperreactivity.

Authors:  Vesla Kullaya; Marien I de Jonge; Jeroen D Langereis; Christa E van der Gaast-de Jongh; Christian Büll; Gosse J Adema; Dirk Lefeber; Amelieke J Cremers; Blandina T Mmbaga; Phillip G de Groot; Quirijn de Mast; Andre J van der Ven
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Glycoprotein IIb-IIIa and the translocation of Rap2B to the platelet cytoskeleton.

Authors:  M Torti; G Ramaschi; F Sinigaglia; E G Lapetina; C Balduini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.

Authors:  E F Plow; G Marguerie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

10.  Regulation of platelet glycoprotein IIb/IIIa (integrin alpha IIB beta 3) function via the thrombin receptor.

Authors:  A N Giesberts; G van Willigen; E G Lapetina; J W Akkerman
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.